Edison Group

EQS Group's (DE:EQSn) Q3 figures show the boost given to its whistleblowing offering by the June acquisition of Business Keeper, lifting the total number of whistleblowing customers to around 1,500....

With the proposed sale of Acal BFi, DiscoverIE (LON:DSCV) is taking the final step to exit the Custom Supply business. Gross proceeds of £50m will be used to reduce debt, providing further...

Newmont's (NYSE:NEM) Q321 results were closely in line with our prior forecasts (see Exhibits 1 and 2), albeit with relative outperformance from its Australian operations largely offsetting...

Foresight Solar Fund (LON:FSFL) is the largest solar investor listed in the UK by installed capacity. With power prices more than tripling in 2021, FSFL’s c 25% merchant share of revenues allows...

Foxtons (LON:FOXT) has traded well ytd, with total revenue exceeding £100m and only c £3m short of the £106.9m reported for the whole of FY19. The company has not only benefited from...

Primary Health Properties (LON:PHP) has announced refinancing measures that enhance debt duration and significantly reduce the running cost of debt. Our forecasts for earnings and fully covered...

Ahead of CentralNic's (LON:CNIC) seasonally strongest quarter, it has reported trading for the first nine months of FY21 (9M21) ahead of market expectations. Noting the acceleration of organic growth...

Borussia Dortmund (DE:BVB) has an established track record as one of the most successful football clubs in Europe. This enables it to exploit structural tailwinds, increasing global and multi-media...

Whitbread (LON:WTB) continues to show that the strong get stronger with Premier Inn, much the largest UK hotel chain, materially outperforming the market throughout H1 to August and to date (by 14% in...

Wandisco (LON:WAND), a company that replicates petabyte scale data to the cloud, last week announced the general availability of its LiveData Migrator on Azure (LDMA). While this could be a...

Kazia Therapeutics (ASX:KZA) is an oncology focused drug development company based in Sydney, Australia. In addition to Kazia’s lead programme, paxalisib, a brain-penetrant inhibitor of the...

Deutsche Börse (DE:DB1Gn) (DB1) is a leading European capital markets infrastructure provider with activities across pre-trading, trading and clearing, and post-trade segments. Its diversity...

BioPorto has announced the appointment of Anthony Pare and Neil Goldman as its new CEO and CFO, respectively, with effect from mid-November 2021. In addition, Thomas Magnussen, chairman of the Board...

Private Canadian biotech firm Hyasynth recently announced a US patent award for using yeast to biosynthesize cannabinoids and is the first to sell yeast-derived cannabidiol (CBD) built on this...

GB Group (LON:GBGP) (GBG) confirmed that its Identity business continued to benefit from a number of exceptional volume drivers in H122, resulting in 12.4% y-o-y organic constant currency revenue...

Love Hemp (AQUIS:LIFE) has established a leading presence in the UK CBD market and is looking to replicate this achievement globally. Key to its success will be product development, the introduction...